Manulife (Manufacturers Life Insurance)’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-39,318
| Closed | -$940K | – | 3376 |
|
|
2021
Q1 | $940K | Sell |
39,318
-2,720
| -6% | -$50.6K | ﹤0.01% | 1928 |
|
|
2020
Q4 | $614K | Buy |
42,038
+1,496
| +4% | +$19.8K | ﹤0.01% | 2078 |
|
|
2020
Q3 | $576K | Hold |
40,542
| – | – | ﹤0.01% | 1935 |
|
|
2020
Q2 | $551K | Buy |
40,542
+3,787
| +10% | +$38.5K | ﹤0.01% | 1916 |
|
|
2020
Q1 | $151K | Buy |
36,755
+2,286
| +7% | +$10.7K | ﹤0.01% | 2445 |
|
|
2019
Q4 | $166K | Sell |
34,469
-1,707
| -5% | -$9.42K | ﹤0.01% | 2657 |
|
|
2019
Q3 | $219K | Hold |
36,176
| – | – | ﹤0.01% | 2530 |
|
|
2019
Q2 | $235K | Buy |
36,176
+1,235
| +4% | +$8.7K | ﹤0.01% | 2529 |
|
|
2019
Q1 | $248K | Buy |
34,941
+924
| +3% | +$6.08K | ﹤0.01% | 2319 |
|
|
2018
Q4 | $166K | Sell |
34,017
-2,236
| -6% | -$11.6K | ﹤0.01% | 2367 |
|
|
2018
Q3 | $267K | Sell |
36,253
-5,352
| -13% | -$39.3K | ﹤0.01% | 2596 |
|
|
2018
Q2 | $265K | Buy |
41,605
+235
| +0.6% | +$1.55K | ﹤0.01% | 2892 |
|
|
2018
Q1 | $225K | Sell |
41,370
-1,915
| -4% | -$9.52K | ﹤0.01% | 2934 |
|
|
2017
Q4 | $181K | Buy |
43,285
+2,883
| +7% | +$17.3K | ﹤0.01% | 3086 |
|
|
2017
Q3 | $389K | Buy |
40,402
+4,379
| +12% | +$45.5K | ﹤0.01% | 2453 |
|
|
2017
Q2 | $426K | Buy |
36,023
+1,410
| +4% | +$18K | ﹤0.01% | 2417 |
|
|
2017
Q1 | $444K | Buy |
34,613
+4,757
| +16% | +$57.3K | ﹤0.01% | 2286 |
|
|
2016
Q4 | $365K | Buy |
29,856
+783
| +3% | +$9.3K | ﹤0.01% | 2331 |
|
|
2016
Q3 | $343K | Sell |
29,073
-581
| -2% | -$5.61K | ﹤0.01% | 2357 |
|
|
2016
Q2 | $258K | Sell |
29,654
-122
| -0.4% | -$836 | ﹤0.01% | 2520 |
|
|
2016
Q1 | $153K | Buy |
29,776
+622
| +2% | +$3.46K | ﹤0.01% | 2790 |
|
|
2015
Q4 | $226 | Hold |
29,154
| – | – | ﹤0.01% | 2564 |
|
|
2015
Q3 | $230 | Hold |
29,154
| – | – | ﹤0.01% | 2532 |
|
|
2015
Q2 | $264 | Buy |
29,154
+350
| +1% | +$3.53K | ﹤0.01% | 2630 |
|
|
2015
Q1 | $374 | Buy |
28,804
+976
| +4% | +$12.8K | ﹤0.01% | 2277 |
|
|
2014
Q4 | $379 | Sell |
27,828
-279
| -1% | -$3.12K | ﹤0.01% | 2171 |
|
|
2014
Q3 | $252 | Sell |
28,107
-448,147
| -94% | -$4.82M | ﹤0.01% | 2471 |
|
|
2014
Q2 | $6.44M | Sell |
476,254
-1,125
| -0.2% | -$11.7K | 0.01% | 869 |
|
|
2014
Q1 | $4.75K | Buy |
477,379
+36,730
| +8% | +$456K | 0.01% | 1037 |
|
|
2013
Q4 | $5.87K | Buy |
440,649
+21,655
| +5% | +$263K | 0.01% | 931 |
|
|
2013
Q3 | $5.09K | Buy |
418,994
+394,304
| +1,597% | +$4.23M | 0.01% | 933 |
|
|
2013
Q2 | $255K | Buy |
+24,690
| New | +$340K | ﹤0.01% | 2374 |
|
Manulife (Manufacturers Life Insurance)'s GNMK Position: Q2 2021 in Review
Manulife (Manufacturers Life Insurance) sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 39,318 shares — an estimated $940K sold.
Manulife (Manufacturers Life Insurance) first reported a position in GNMK in Q2 2013 and held it in 32 quarters. The position peaked at $6.44M in Q2 2014. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Manulife (Manufacturers Life Insurance) reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 39,318 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $940K.
- Manulife (Manufacturers Life Insurance) first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 32 quarters.
- Manulife (Manufacturers Life Insurance)'s GenMark Diagnostics, Inc position peaked at $6.44M in Q2 2014.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2021, filed 12 Aug 2021.